NFKB1 and viral encephalitis: Inhibition of NF-κB activation has shown promising results in reducing neuroinflammation in preclinical models of various neurological disorders, including viral encephalitis (Gu et al., 2012; Moniuszko-Malinowska et al., 2017; Wang et al., 2022).